C000237308 Fees and Costs — Putnam BioRevolution ETF
Data updated: 2025-12-29
The net expense ratio is 0.70%. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $574 in broker commissions, 0.0107% of average net assets, and portfolio turnover was 32%.
C000237308 Fees and Expenses
Annual operating expenses and sales charges of C000237308. Prospectus, as of April 30, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.70% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.70% |
| Fee waiver | — |
| Net expense ratio | 0.70% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
C000237308 Costs Over Time
On $10,000 invested in C000237308, assuming 5% a year before costs, total costs come to $447 over 5 years, cutting the return by 0.75% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.70%) | $74 | $230 | $400 |
| Trading costs (broker commissions) | $1 | $4 | $6 |
| Lost growth on money paid in costs | $0 | $12 | $41 |
| Total costs | $75 | $245 | $447 |
| Value after costs | $10,425 | $11,331 | $12,316 |
| Impact on return, per year | 0.75% | 0.75% | 0.75% |
C000237308 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending April 30, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0107%
- Total broker commissions: $574
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 32%
- Securities lending: none during the year
C000237308 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| UBSW - UBS SECURITIES L.L.C. | $170 | 29.62% |
| JPMS - J.P. MORGAN SECURITIES, LLC. | $146 | 25.56% |
| MLCO - BofA Securities, Inc. | $131 | 22.79% |
| GSCO - GOLDMAN SACHS & CO LLC | $38 | 6.59% |
| RBCD - RBC CAPITAL MARKETS LLC | $31 | 5.40% |
| COWN - COWEN & COMPANY, L.L.C. | $26 | 4.50% |
| STFL - STIFEL, NICOLAUS & COMPANY INCORPORATED | $19 | 3.38% |
| BARD - BAIRD (ROBERT W.) & CO., INCORPORATED | $10 | 1.78% |
| CANT - CANTOR FITZGERALD & CO. | $1 | 0.25% |
| FSB - Fidelity Service Bureau | $1 | 0.13% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.